ArticleNature communications2024

Effectiveness of nirmatrelvir/ritonavir in children and adolescents aged 12-17 years following SARS-CoV-2 Omicron infection: A target trial emulation.

Carlos K H Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.